Mangoceuticals, Inc. (MGRX) vs Traws Pharma, Inc. (TRAW)
A side-by-side comparison of Mangoceuticals, Inc. and Traws Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MGRX
Mangoceuticals, Inc.
$0.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TRAW
Traws Pharma, Inc.
$0.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MGRX vs TRAW
growth of $100 · dividends reinvested · last 4yMGRX -99.3% (-71.1%/yr)TRAW -97.3% (-59.5%/yr)TRAW compounded faster over this window
MGRX TRAW
MGRX vs TRAW: by the numbers
- •TRAW is the larger company ($8M vs $8M market cap).
- •TRAW is profitable (328.67% net margin) while MGRX runs a net loss (-4791.48%).
Metrics side by side
Valuation
| Metric | MGRX | TRAW |
|---|---|---|
| P/S ratio | 24.22 | N/A |
| P/B ratio | 0.61 | N/A |
Profitability
| Metric | MGRX | TRAW |
|---|---|---|
| Gross margin | 54.43% | 100.00% |
| Operating margin | -4200.46% | -640.68% |
| Net margin | -4791.48% | 328.67% |
| ROE | -120.58% | N/A |
| ROIC | -102.91% | N/A |
Growth (annualized)
| Metric | MGRX | TRAW |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 64.60% |
| Total return CAGR (5Y) | N/A | -64.14% |
Frequently asked
- Is MGRX or TRAW more profitable?
- TRAW runs the higher net margin — MGRX at -4791.48% versus TRAW at 328.67%.
Go deeper
Dig into the metrics
Mangoceuticals ROETraws Pharma ROEMangoceuticals operating marginTraws Pharma operating marginMangoceuticals revenue growthTraws Pharma revenue growthMangoceuticals free cash flowTraws Pharma free cash flow
Mangoceuticals & Traws Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.